Skip to main content
Clinical Trials/NCT06249789
NCT06249789
Not yet recruiting
Not Applicable

Enhancing Recovery in Hip Fracture Surgeries

Hartford Hospital0 sites102 target enrollmentStarted: February 2024Last updated:
ConditionsHip Fractures

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
102
Primary Endpoint
Measuring Pain: Visual Analog Scale (VAS)

Overview

Brief Summary

The purpose of this study is to look at how two different types of anesthesia, spinal and general, affect participants with broken hips who are getting a special kind of pain block before surgery.

Researchers will check:

  • How quickly patients are ready for anesthesia
  • How long they stay in the recovery room after surgery
  • How much pain medicine they need during recovery
  • If they experience any confusion
  • If one group has complications in one of these anesthesia techniques?

Participants in the study will be put into one of two groups by chance to see if there's a difference in their recovery.

Detailed Description

This clinical trial aims to compare two common anesthesia techniques, spinal and general anesthesia, combined with a preoperative nerve block called the Fascia Iliaca Compartment Block (FICB). The objective is to understand how these methods affect patients undergoing hip fracture surgery.

The main questions this study aims to answer are:

  • Does the choice between spinal and general anesthesia influence how quickly patients recover from anesthesia?
  • Does it affect how long patients stay in the Post-Anesthesia Care Unit (PACU)?
  • Does it change the amount of opioid pain medication needed after surgery?
  • Do the different anesthesia types impact the occurrence of postoperative delirium?
  • Do they affect the length of the hospital stay after surgery?
  • Do they lead to different rates of post-operative complications?

Participants will:

  • Receive either spinal anesthesia with Fascia Iliaca Compartment Block (FICB) (Arm A) or general anesthesia with Fascia Iliaca Compartment Block (FICB) (Arm B).
  • Undergo an ultrasound-guided FICB injection.
  • Receive appropriate anesthesia and sedation during surgery.
  • Be monitored for pain and provided with pain relief as needed.

The study's broader objectives include enhancing patient safety and satisfaction, reducing hospital readmission rates, lowering healthcare costs, and improving overall healthcare practices. Although direct benefits to participants are not guaranteed, the findings will inform better care for future patients with hip fractures.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

The outcome evaluators and analysts would be unaware of which treatment the participants received.

Eligibility Criteria

Ages
60 Years to 89 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients meeting all of the following criteria will be included:
  • any gender
  • any race/ethnicity
  • age 60-89 years
  • admitted to St Vincent's Medical Center (SVMC) for elective hip fracture: intramedullary (IM) nailing or open reduction internal fixation (ORIF)
  • able to communicate in English or Spanish

Exclusion Criteria

  • Patients meeting any of the following criteria will be excluded:
  • age \<60 or ≥90 years old
  • Body Mass Index (BMI) \>50 kg/m2
  • not ambulatory prior to the fracture
  • have a current daily Morphine Equivalent Dose (MED) surpassing 20-milligram equivalents (MME)
  • communicate in a language other than English or Spanish (due to lack of availability of translators and issues with patient management if dependent on the Hartford Health Center (HHC) language line)
  • history of substance abuse, which might interfere with anesthesia administration, pain management, and overall study outcomes
  • have undergone previous hip surgery on the side of the fracture
  • refusal to participate or lack of signed study informed consent from the patient or their proxy (in cases where patients lack the capacity to consent)
  • have absolute contraindications to spinal anesthesia, determined preoperatively by the regional anesthesiologist in charge, such as:

Outcomes

Primary Outcomes

Measuring Pain: Visual Analog Scale (VAS)

Time Frame: Postoperative Anesthesia Unit (PACU) stay: Approximately 2-4 hours from arrival to PACU to release to the floor.

The pain scale ranges from 0, no pain, to 10, the worst pain imaginable.

Post-Anesthesia Care Unit Stay

Time Frame: Approximately 2-4 hours: From the moment the patient arrives in the Post Anesthesia Care Unit (PACU) until their departure to the floor..

The Aldrete Score, used in the PACU, rates from 0 to 10 for discharge readiness. Higher scores mean patients' vital signs are stable; lower scores require more recovery time.

Postoperative complications:

Time Frame: Monitoring for PONV, DVT, and cardiac/pulmonary issues occurs at 24, 48, and 72 hours post-admission for observation.

We are monitoring post-op complications like episodes of postoperative nausea and vomiting (PONV) with the "PONV impact Scale" in the postoperative care unit, the presence of infections, thrombosis (DVT), and pulmonary and heart issues. PONV will be assessed in PACU; a score ≥5 on the PONV Scale is significant.

Post-anesthesia Care Unit (PACU) Opioid consumption

Time Frame: Approximately 2-4 hours: From the moment the patient arrives in the Post Anesthesia Care Unit (PACU) until their departure to the floor..

Post-anesthesia opioid use is measured in milligrams (Morphine Equivalent table) and tracked in the PACU to manage pain. Lower use suggests reasonable pain control; higher use indicates more pain and inadequate control.

Post-Surgery Hospital Stay

Time Frame: Post-surgery stay is hospital typically 7-10 days for recovery and complication management. Extended stays may signal recovery delays.

The period between the end of the surgical procedure and hospital discharge.

Secondary Outcomes

  • Cognitive impairment and delirium(We measure at two point 1) Pre-operative 2) on post operative day one)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Haleh Saadat

Associate Clinical Professor of Anesthesiology

Hartford Hospital

Similar Trials